These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 26301677

  • 21. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 22. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 23. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium.
    Blood Press; 2015 May; 24(5):263-74. PubMed ID: 26194721
    [Abstract] [Full Text] [Related]

  • 24. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 25. The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up.
    Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM.
    Blood Press; 2021 Feb 10; 30(1):41-50. PubMed ID: 33030064
    [Abstract] [Full Text] [Related]

  • 26. Predictors of blood pressure response: Obesity is associated with a less pronounced treatment response after renal denervation.
    Id D, Bertog SC, Ziegler AK, Hornung M, Hofmann I, Vaskelyte L, Matic P, Gafoor S, Sievert H.
    Catheter Cardiovasc Interv; 2016 Jan 01; 87(1):E30-8. PubMed ID: 26104216
    [Abstract] [Full Text] [Related]

  • 27. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A, Ditting T, Sobotka PA, Veelken R, Schmieder RE, Uder M, Ott C.
    Cardiovasc Intervent Radiol; 2013 Aug 01; 36(4):987-91. PubMed ID: 23771326
    [Abstract] [Full Text] [Related]

  • 28. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.
    EuroIntervention; 2015 Feb 01; 10(10):1213-20. PubMed ID: 25452197
    [Abstract] [Full Text] [Related]

  • 29. Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy.
    Tsioufis C, Papademetriou V, Dimitriadis K, Tsiachris D, Thomopoulos C, Kasiakogias A, Kordalis A, Kefala A, Koutra E, Lau EO, Grassi G, Stefanadis C.
    J Hypertens; 2015 Feb 01; 33(2):346-53. PubMed ID: 25380167
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S, Dörr O, Ukena C, Linz D, Cremers B, Laufs U, Hamm C, Nef H, Bauer A, Mancia G, Böhm M, Mahfoud F.
    J Hypertens; 2015 Dec 01; 33(12):2512-8. PubMed ID: 26485461
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.
    Al Raisi SI, Pouliopoulos J, Qian P, King P, Byth K, Barry MT, Swinnen J, Thiagalingam A, Kovoor P.
    Catheter Cardiovasc Interv; 2019 Feb 15; 93(3):E105-E111. PubMed ID: 30549404
    [Abstract] [Full Text] [Related]

  • 35. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A.
    J Hypertens; 2016 Aug 15; 34(8):1639-47. PubMed ID: 27228432
    [Abstract] [Full Text] [Related]

  • 36. Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation.
    Prochnau D, Heymel S, Otto S, Figulla HR, Surber R.
    EuroIntervention; 2014 Sep 15; 10(5):640-5. PubMed ID: 25256203
    [Abstract] [Full Text] [Related]

  • 37. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul 15; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.